Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $6.89B | $43.86 | $40.00 | -8.80% | Buy | 3 | 41.64% | 149.97% | 252.17% | 97.07% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.12B | $8.12 | N/A | N/A | N/A | N/A | 24.09% | 213.21% | 64.76% | 44.40% | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.73B | $73.23 | $143.25 | 95.62% | Strong Buy | 4 | 28.82% | 52.97% | 116.05% | 93.82% | |||
| KRYS | KRYSTAL BIOTECH INC | $4.91B | $170.57 | $226.60 | 32.85% | Strong Buy | 5 | 39.19% | 58.87% | 42.32% | 37.94% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $604.90M | $7.78 | $9.03 | 16.11% | Strong Buy | 3 | 20.03% | 35.96% | 45.54% | 30.75% | |||
| SPRY | ARS PHARMACEUTICALS INC | $1.37B | $13.92 | $28.33 | 103.54% | Strong Buy | 3 | 59.45% | 56.74% | 56.68% | 41.45% | |||
| GYRE | GYRE THERAPEUTICS INC | $895.87M | $9.57 | N/A | N/A | N/A | N/A | 49.51% | 132.23% | 428.74% | 216.48% | |||
| ARGX | ARGENX SE | $38.25B | $629.51 | $740.71 | 17.67% | Strong Buy | 14 | 973.96% | 24.89% | 38.84% | 34.43% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.95B | $24.28 | $33.20 | 36.74% | Strong Buy | 5 | 14.80% | 21.62% | 44.40% | 37.94% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.69B | $29.44 | $54.86 | 86.33% | Strong Buy | 7 | 17.47% | 25.64% | 55.91% | 36.88% | |||
| VCEL | VERICEL CORP | $1.97B | $39.36 | $61.80 | 57.01% | Strong Buy | 5 | 25.85% | 79.15% | 33.55% | 22.63% | |||
| EXEL | EXELIXIS INC | $10.79B | $38.55 | $37.81 | -1.91% | Buy | 16 | 10.51% | 22.66% | 59.24% | 45.10% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $5.90B | $60.85 | $129.39 | 112.63% | Buy | 13 | 30.93% | 83.31% | 87.92% | 33.89% | |||
| HALO | HALOZYME THERAPEUTICS INC | $7.49B | $60.82 | $64.67 | 6.33% | Buy | 6 | 19.49% | 30.11% | 297.54% | 52.46% | |||
| RIGL | RIGEL PHARMACEUTICALS INC | $349.58M | $19.57 | $36.80 | 88.04% | Buy | 5 | 12.31% | 31.54% | 1,733.05% | 34.75% | |||
| RPRX | ROYALTY PHARMA PLC | $18.86B | $32.71 | N/A | N/A | N/A | N/A | 19.38% | 62.41% | 30.52% | 17.32% | |||
| NVO | NOVO NORDISK A S | $290.94B | $65.16 | $112.00 | 71.88% | Buy | 2 | 15.61% | 18.81% | 127.89% | 39.40% | |||
| MDXG | MIMEDX GROUP INC | $1.02B | $6.92 | $13.00 | 87.86% | Strong Buy | 1 | 12.33% | 33.56% | N/A | N/A | |||
| MNKD | MANNKIND CORP | $1.49B | $4.91 | $9.50 | 93.48% | Strong Buy | 2 | 15.08% | 46.28% | -173.34% | 34.69% | |||
| ADMA | ADMA BIOLOGICS INC | $5.73B | $24.11 | $25.33 | 5.07% | Strong Buy | 3 | 20.25% | 10.07% | 98.04% | 70.02% | |||
| INCY | INCYTE CORP | $11.70B | $60.43 | $74.36 | 23.05% | Hold | 14 | 8.47% | 197.42% | 47.53% | 30.32% | |||
| GNFT | GENFIT SA | $202.48M | $4.05 | $13.00 | 220.99% | Buy | 1 | -2.57% | 77.90% | -55.93% | -25.57% | |||
| VCYT | VERACYTE INC | $2.45B | $31.38 | $42.00 | 33.84% | Buy | 8 | 10.44% | 71.34% | 7.69% | 6.95% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.07B | $116.41 | $188.67 | 62.07% | Strong Buy | 12 | 5.55% | 31.52% | N/A | N/A | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12.07B | $63.28 | $93.85 | 48.30% | Buy | 13 | 10.04% | 32.25% | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $7.98B | $50.50 | $78.83 | 56.10% | Buy | 6 | 5.97% | 39.71% | N/A | N/A | |||
| GMAB | GENMAB A | $13.76B | $20.79 | $39.25 | 88.79% | Strong Buy | 4 | 18.35% | 12.82% | 4.49% | 3.60% | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.41B | $14.43 | $23.86 | 65.33% | Buy | 7 | 10.44% | 4.72% | 50.55% | 31.19% | |||
| UTHR | UNITED THERAPEUTICS CORP | $13.51B | $300.76 | $392.11 | 30.37% | Buy | 9 | 6.49% | 1.90% | 23.62% | 20.67% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $61.42B | $568.91 | $926.67 | 62.88% | Buy | 18 | 5.74% | 0.88% | 21.93% | 17.16% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.